Col. Campestre Churubusco, Mexico

Alicia Cervantes


Average Co-Inventor Count = 17.2

ph-index = 6

Forward Citations = 117(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1996)
  • Mexico City, MX (1996)
  • Mexico D. F., MX (1996)
  • Col. Campestre Churubusco, MX (1995 - 1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Alicia Cervantes: Innovator in Therapeutic Agents

Introduction

Alicia Cervantes is a prominent inventor based in Col. Campestre Churubusco, Mexico. She has made significant contributions to the field of therapeutic agents, holding a total of eight patents. Her work focuses on developing innovative solutions for various medical conditions.

Latest Patents

Cervantes' latest patents include the development of 5-substituted derivatives of mycophenolic acid. These hexenoic acid side-chain derivatives are recognized as therapeutic agents beneficial in treating disease states indicated for mycophenolic acid and/or mycophenolate mofetil. This includes conditions such as immune, inflammatory, tumor, proliferative, viral, or psoriatic disorders. Another notable patent is for 4-amino 6-substituted mycophenolic acid and its derivatives. These derivatives are also advantageous in treating disease states indicated for mycophenolic acid and/or mycophenolate mofetil, as well as other immunosuppressant agents.

Career Highlights

Throughout her career, Cervantes has worked with various companies, including Syntex (U.S.A.) Inc. Her experience in the pharmaceutical industry has allowed her to contribute significantly to the development of therapeutic agents.

Collaborations

Cervantes has collaborated with notable individuals in her field, including David John Morgans, Jr. and David Bernard Smith. These collaborations have further enhanced her research and development efforts.

Conclusion

Alicia Cervantes is a remarkable inventor whose work in therapeutic agents has the potential to impact many lives. Her innovative patents and collaborations highlight her dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…